期刊文献+

皮肌炎肌组织中浆细胞样树突状细胞的病理学特点 被引量:2

The pathological characteristics of plasmacytoid dendritic cells in muscle tissue of dermatomyositis
原文传递
导出
摘要 目的 研究皮肌炎肌组织中浆细胞样树突状细胞(pDC)的病理学特点,探讨其病理学意义.方法 收集30例皮肌炎及25例多发性肌炎(PM)患者的肌肉活体组织标本,全部行HE染色、免疫组织化学(抗CD303分子及抗CD68分子)染色.结果 肌活体组织检查病理示,30例皮肌炎中25例可见典型束周萎缩,伴肌束膜明显增宽,5例束周萎缩不典型,但于肌束周边可见小群坏死或再生纤维;14例可见束周凿空样纤维;17例可见肌束膜内血管周围炎,6例于肌内膜可见灶性炎症细胞浸润.免疫组织化学染色示,19例在肌束膜及血管周围可见较多巨噬细胞浸润;20例可见较多pDC浸润,其中,15例此细胞仅位于宽大肌束膜内血管周围的灶性炎细胞区域,3例仅位于肌内膜灶性炎症细胞区域,2例pDC在上述2个部位均存在.25例PM患者的主要病理改变为坏死、再生纤维及炎症细胞浸润,免疫组织化学染色在血管周围灶性炎症细胞区域未发现或偶见少量散在pDC的浸润.结论 在PM患者肌组织中未发现或偶见少量散在pDC的浸润,而在皮肌炎患者肌组织内可见显著pDC的浸润,且其主要在宽大肌束膜内的血管周围分布的特点提示可能与皮肌炎束周萎缩的形成有关. Objective To study the histological features of plasmacytoid dendritic cells (pDC) in muscle tissue affected by dermatomyositis (DM) and to discuss the pathological significations of pDC.Methods Muscle tissues from 30 cases of DM and 25 cases of polymyositis (PM) were collected.HE stain, immunohistochemistry studies were carried out in all muscle samples.Results Pathological features of DM included: perifascicular atrophy (25/30); punched-out fiber (14/30); perivasculitis (17/30),inflammatory infiltration in the endomysium(6/30).Using immunohistochemistry study, 19 cases from DM were infiltrated by macrophages which are CD68 positive and CD303 negative, 20 cases with DM were infiltrated by pDC which are CD303 positive.The location of pDC were: perivascular of interfascicular septae only (15/20); endomysium only (3/20) and both (2/20).Myopathic damage such as necrotic and regenerating fibers and inflammatory infiltration could be seen in PM.There was few pDC infiltration in PM.Conclusions There is few pDC in muscle tissue affected by PM and many pDC in muscle tissue affected by DM with infiltration mainly in the wide interfascicular septae.pDC may be connected to perifascicular atrophy and play a roll in the pathogenesis of DM.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2011年第3期174-177,共4页 Chinese Journal of Neurology
基金 基金项目:山东省优秀中青年科学家科研奖励基金资助项目(2008BS03023) 济南市卫生局留学人员创业计划资助项目(20080406)
关键词 皮肌炎 树突细胞 抗原 CD 免疫组织化学 Dermatomyositis Dendritic cells Antigens,CD Immunohistochemistry
  • 相关文献

参考文献15

  • 1Dalakas MC,Hohlfeld R.Polymyositis and dermatomyositis.Lancet,2003,362:971-982.
  • 2Dalakas MC.Polymyositis,dermatomyositis and inclusion-body myositis.N Engl J Med,1991,325:1487-1498.
  • 3Dalakas MC.Muscle biopsy findings in inflammatory myopathies.Rheum Dis Clin North Am,2002,28:779-798.
  • 4吴萍萍 ,王建莉 ,曹雪涛 .浆细胞样树突状细胞研究进展[J].国外医学(免疫学分册),2005,28(4):204-209. 被引量:3
  • 5Beilke MA,Traina-Dorge V,England JD,et al.Polymyositis,arthritis and uveitis in a macaque experimentally infected with human T lymphotropic virus type Ⅰ.Arthitis Rheum,1996,39:610-614.
  • 6Dalakas MC.Immunopathogenesis of inflammatory myopathies.Ann Neurol,1995,37 Suppl 1:S74-86.
  • 7Greenberg SA.Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications.Neurology,2007,69:2008-2019.
  • 8Karpati G,Carpenter S,Melmed C,et al.Experimental ischemic myopathy.J Neurol Sci,1974,23:129-161.
  • 9López de Padilla CM,Vallejo AN,McNallan KT,et al.Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis.Arthritis Rheum,2007,56:1658-1668.
  • 10Fuchsberger M,Hochrein H,O' Keeffe M.Activation of plasmacytoid dendritic cells.Immunol Cell Biol,2005,83:571-577.

二级参考文献21

  • 1陈琳,1991年
  • 2Chou S M,Arch Pathol Lab,1981年,105卷,76页
  • 3Blom B, Ho S, Antonenko S, et al. Generation of interferon alpha-prnducing predendritic cell (pre-DC)2 from human CD34(+) hematopoietic stem cells[J].J Exp Med,2000,192(12): 1785-1796.
  • 4Spits H, Couwenberg F, Bakker AQ, et al. Id2 and Id3 inhibit development of CDM(+) stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2[J].J Exp Med,2000,192(12): 1775-1784.
  • 5Weijer K, Uittenbogaart CH, Voordouw A, et al. Intrathy-mic and extrathymic development of human plasmacytoid dendritic cell precursors in vivo[J]. Blood,2002,99(8):2752-2759.
  • 6Rissoan MC, Duhen T, Bfidon JM, et al. Subtractive hybridization reveals the expression of immunoglobulin-like trasncript 7, Eph-B1, granzyme B,and three novel transcripts in human plasmacytoid dendritic cells [J].Blood, 2002,100(9):3295-3303.
  • 7Schotte R, Rissoan MC, Bendfiss-Vermare N, et al.The transcription factor Spi-B is expm.s,sed in plasmacytoid DC precursors and inhibits T, B and NK cell development[J]. Blood, 2003,101(3): 1015-1023.
  • 8Bianea B, Suzanne J, Schotte R, et al. Developmental origin of Pre-DC2[J]. Hum Immunol,2002,63(12):1072-1080.
  • 9Ito T, Inaba M,Inaba K,et al.A CD1a^+/CD11c^+ subset of human blood dendritic cells is a direct precursor of Langerhans cells[J]. J Immunol,1999,163(3):1409-1419.
  • 10Belmont HM, Buyon J, Giomo R, et al. Upregulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. The Shwartzman phenomenon revisited[J]. Arthritis Rheum, 1994,37(3):376-383.

共引文献8

同被引文献32

  • 1Vincze M,Danko K. Idiopathic inflammatory myopathies. BestPract Res Clin Obstet Gynaecol,2012,26(1) : 25-45 .
  • 2Bohan A,Peter JB. Polymyositis and dermatomyositis ( firstof two parts ) . N Engl J Med , 1975 , 292(2): 344-347.
  • 3Bohan A,Peter JB . Polymyositis and dermatomyositis ( sec-ond of two parts ) . N Engl J Med,1975,292(2) : 403 -407.
  • 4Daiakas MC,Hohlfeld R. Polymyositis and dermatomyositis .Lancet, 2003 , 362(9388 ) ; 971-982.
  • 5Hoogendijk JE,Amato AA,Lecky BR,et al. 119 the EN-MC international workshop : trial design in adult idiopathic in-flammatory myopathies,with the exception of inclusion bodymyositis. Neuromuscul Disord , 2004,14(5) : 337 -345 .
  • 6Allenbach Y,Benveniste 0 , Decostre V , et al. Quadricepsstrength is a sensitive marker of disease progression in sporadicinclusion body myositis. Neuromuscul Disord, 2012, 22(11): 980-986.
  • 7C alien JP. Cutaneous manifestations of dermatomyositis andtheir management. Curr Rheumatol Rep , 2010, 12(3):192-197.
  • 8De Souza FH,Shinjo SK. Newly diagnosed dermatomyositis inthe elderly as predictor of malignancy. Rev Bras Reumatol,2012,52(5) : 713-721.
  • 9Daiakas MC. Immunotherapy of myositis : issues,concernsand future prospects. Nat Rev Rheumatol,2010, 6(3):129-137.
  • 10Hengstman GJ, van Engelen BG,van Venrooij WJ , et al.Myositis specific autoantibodies : changing insights in patho-physiology and clinical associations. Curr Opin Rheumatol,2004, 16(6) : 692-699.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部